Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma

Young Hoon HwangDepartment of Ophthalmology, Konyang University, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Seoul, KoreaI read with interest the article entitled "Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension&qu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Hwang YH
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/a54bcefee7cd4c1684517823f43aa49c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a54bcefee7cd4c1684517823f43aa49c
record_format	dspace
spelling	oai:doaj.org-article:a54bcefee7cd4c1684517823f43aa49c2021-12-02T06:57:31ZEfficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma1177-5483https://doaj.org/article/a54bcefee7cd4c1684517823f43aa49c2013-12-01T00:00:00Zhttp://www.dovepress.com/efficacy-and-tolerability-of-preservative-free-tafluprost-00015-in-kor-a15312https://doaj.org/toc/1177-5483 Young Hoon HwangDepartment of Ophthalmology, Konyang University, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Seoul, KoreaI read with interest the article entitled "Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension" by Lanzl et al.1 I have also experienced similar treatment outcomes in Korean patients. In Korea, preservative-free tafluprost (Taflotan-S; Santen Pharmaceutical Co, Ltd, Osaka, Japan) was introduced to the ophthalmic market in October 2012. Thus far, no data have been published on the efficacy and tolerability of preservative-free tafluprost in Korean patients. Thus, I investigated the intraocular pressure (IOP)-lowering efficacy and safety of preservative-free tafluprost in treatment-naïve Korean patients with glaucoma.View original paper by Lanzl and colleagues.Hwang YHDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 71-72 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Hwang YH Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
description	Young Hoon HwangDepartment of Ophthalmology, Konyang University, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Seoul, KoreaI read with interest the article entitled "Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension" by Lanzl et al.1 I have also experienced similar treatment outcomes in Korean patients. In Korea, preservative-free tafluprost (Taflotan-S; Santen Pharmaceutical Co, Ltd, Osaka, Japan) was introduced to the ophthalmic market in October 2012. Thus far, no data have been published on the efficacy and tolerability of preservative-free tafluprost in Korean patients. Thus, I investigated the intraocular pressure (IOP)-lowering efficacy and safety of preservative-free tafluprost in treatment-naïve Korean patients with glaucoma.View original paper by Lanzl and colleagues.
format	article
author	Hwang YH
author_facet	Hwang YH
author_sort	Hwang YH
title	Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
title_short	Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
title_full	Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
title_fullStr	Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
title_full_unstemmed	Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
title_sort	efficacy and tolerability of preservative-free tafluprost 0.0015% in korean patients with glaucoma
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/a54bcefee7cd4c1684517823f43aa49c
work_keys_str_mv	AT hwangyh efficacyandtolerabilityofpreservativefreetafluprost00015inkoreanpatientswithglaucoma
_version_	1718399652457349120

Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma

Ejemplares similares